Vernakalant-facilitated electrical cardioversion: comparison of intravenous vernakalant and amiodarone for drug-enhanced electrical cardioversion of atrial fibrillation after failed electrical cardioversion

Feasibility of a cardiologist-only approach to sedation for electrical cardioversion of atrial fibrillation: A randomized, open-blinded, prospective study

(2014) Federico Guerra et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Pharmacological cardioversion of atrial fibrillation with vernakalant: evidence in support of the ESC Guidelines

(2013) I. Savelieva et al.   EUROPACE

Vernakalant versus electrical cardioversion in recent-onset atrial fibrillation

(2013) Diego Conde et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

The Use of Ranolazine to Facilitate Electrical Cardioversion in Cardioversion-Resistant Patients: A Case Series

(2012) DAVID K. MURDOCK et al.   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY

A Randomized Active-Controlled Study Comparing the Efficacy and Safety of Vernakalant to Amiodarone in Recent-Onset Atrial Fibrillation

(2011) A. John Camm et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPACE